Literature DB >> 21782823

EUVAC.NET collaborative study: evaluation and standardisation of serology for diagnosis of pertussis.

Dorothy Xing1, Kevin Markey, Penny Newland, Peter Rigsby, Jason Hockley, Qiushui He.   

Abstract

As part of the new EUVAC.NET contract with ECDC (Pertussis Work Area 4), a collaborative study was organised in July-December 2010. Two well-defined reference preparations with high and low IgG antibodies to pertussis toxin (PT), were sent to participants. The purposes of this study were to assess current laboratory performance of serological assays for pertussis; to compare in-house reference preparations that are currently used by participants for the serological assay; and to identify needs for standardisation of the serological assay. Reference Laboratories in Europe currently performing serological assays for the diagnosis of pertussis by measuring antibody to PT, were invited to participate in the study. A total of 17 laboratories/countries participated in this study. Results were reported from a total of 9 participants who used in-house ELISA assays and 10 participants who used commercial kits. All participants using in-house ELISA with purified PT coating plates distinguished the 2 preparations and gave results that were comparable to the expected values. A total of 6 commercial kits included in the study showed different results. The kits coated with mixture antigens did not appear to be able to give results that were correlated to the WHO reference preparations.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21782823     DOI: 10.1016/j.jim.2011.07.005

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  7 in total

1.  Comparative study of different sources of pertussis toxin (PT) as coating antigens in IgG anti-PT enzyme-linked immunosorbent assays.

Authors:  Aditi Kapasi; Bruce D Meade; Brian Plikaytis; Lucia Pawloski; Monte D Martin; Sandra Yoder; Michael T Rock; Séverine Coddens; Valérie Haezebroeck; Françoise Fievet-Groyne; Garvin Bixler; Charles Jones; Stephen Hildreth; Kathryn M Edwards; Nancy E Messonnier; Maria L Tondella
Journal:  Clin Vaccine Immunol       Date:  2011-11-23

2.  Seroprevalence of antibodies against measles, rubella, mumps, varicella-zoster, and B. Pertussis in young adults of Madrid, Spain.

Authors:  Alba González-Escalada; Laura García-García; Pablo Viguera-Ester; Patricia Marín-García; Jesus García; Angel Gil-de-Miguel; Ruth Gil-Prieto
Journal:  Hum Vaccin Immunother       Date:  2013-06-21       Impact factor: 3.452

3.  Evaluation of PCR methods for the diagnosis of pertussis by the European surveillance network for vaccine-preventable diseases (EUVAC.NET).

Authors:  T Dalby; N K Fry; K A Krogfelt; J S Jensen; Q He
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-04-23       Impact factor: 3.267

4.  A Belgian Serosurveillance/Seroprevalence Study of Diphtheria, Tetanus and Pertussis Using a Luminex xMAP Technology-Based Pentaplex.

Authors:  Raissa Nadège Caboré; Denis Piérard; Kris Huygen
Journal:  Vaccines (Basel)       Date:  2016-05-10

5.  Pertussis surveillance and control: exploring variations and delays in testing, laboratory diagnostics and public health service notifications, the Netherlands, 2010 to 2013.

Authors:  Jeanne Heil; Henriëtte L G Ter Waarbeek; Christian J P A Hoebe; Peter H A Jacobs; Dirk W van Dam; Thera A M Trienekens; Jochen W L Cals; Inge H M van Loo; Nicole H T M Dukers-Muijrers
Journal:  Euro Surveill       Date:  2017-07-13

6.  Lack of association between mannose binding lectin and antibody responses after acellular pertussis vaccinations.

Authors:  Kirsi Gröndahl-Yli-Hannuksela; Juho Vuononvirta; Ville Peltola; Jussi Mertsola; Qiushui He
Journal:  PLoS One       Date:  2014-02-18       Impact factor: 3.240

7.  Safety and immunogenicity of a combined Tetanus, Diphtheria, recombinant acellular Pertussis vaccine (TdaP) in healthy Thai adults.

Authors:  Chukiat Sirivichayakul; Pornthep Chanthavanich; Kriengsak Limkittikul; Claire-Anne Siegrist; Wassana Wijagkanalan; Pailinrut Chinwangso; Jean Petre; Pham Hong Thai; Mukesh Chauhan; Simonetta Viviani
Journal:  Hum Vaccin Immunother       Date:  2016-09-29       Impact factor: 3.452

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.